Early detection and monitoring of neurodegenerative diseases using a multi-disease diagnostic platform
Patent Information
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- DURIN LIFE SCIENCES INC
- Filing Date
- 2023-07-27
- Publication Date
- 2026-07-15
AI Technical Summary
Current methods for diagnosing neurodegenerative diseases like Alzheimer's and Parkinson's are invasive, expensive, and lack accuracy for early-stage detection, making it difficult to initiate timely treatment and monitor disease progression effectively.
A multi-disease diagnostic platform using a protein target set that forms immunocomplexes with specific autoantibody biomarkers in biological samples, combined with a classification algorithm, to detect and quantify AD- and PD-related autoantibodies in blood samples, enabling early-stage diagnosis and monitoring.
The platform achieves high accuracy in detecting early-stage neurodegenerative diseases, with a detection accuracy of at least 75% for AD and 87.9% for PD, allowing for early intervention and monitoring of disease progression.
Smart Images
Figure 1.1